Synthesis of novel phenylacetic acid derivatives with halogenated benzyl subunit and evaluation as aldose reductase inhibitors

European Journal of Pharmaceutical Sciences

Volumn 27, Issue 2-3, 2006, Pages 188-193

  Rakowitz, Dietmar ^a   Gmeiner, Andreas ^a   Schröder, Nicole ^a   Matuszczak, Barbara ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Aldose reductase; Enzyme inhibitors; Inhibitor; Substituted phenylacetic acids

Indexed keywords

3 (4 BROMO 2 FLUOROBENZYLOXY)PHENYLACETIC ACID; ALDOSE REDUCTASE INHIBITOR; BENZOIC ACID DERIVATIVE; BENZYL DERIVATIVE; CARBENE; PHENYLACETIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; DRUG SYNTHESIS; ENZYME INHIBITION; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL;

ALDEHYDE REDUCTASE; ANIMALS; BENZOIC ACIDS; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HYDROCARBONS, HALOGENATED; PHENYLACETATES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 29244443245     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2005.09.006     Document Type: Article

References (13)

1. T.-C. Chou, and M.P. Hayball CalcuSyn Software Version 1.1.1 1996 Biosoft Cambridge, UK
2. L. Costantino, G. Rastelli, K. Vescovini, G. Cignarella, P. Vianello, A. Del Corso, M. Cappiello, U. Mura, and D. Barlocco Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors J. Med. Chem. 39 1996 4396 4405
3. L. Costantino, G. Rastelli, G. Cignarella, P. Vianello, and D. Barlocco New aldose reductase inhibitors as potential agents for the prevention of long-term diabetic complications Exp. Opin. Ther. Patents 7 1997 843 858
4. E.I. Howard, R. Sanishvili, R.E. Cachau, A. Mitschler, B. Chevrier, P. Barth, V. Lamour, M. Van Zandt, E. Sibley, C. Bon, D. Moras, T.R. Schneider, A. Joachimiak, and A. Podjarny Ultrahigh resolution drug design. I. Details of interactions in human aldose reductase-inhibitor complex at 0.66 Å Proteins 55 2004 792 804
5. T. Kinoshita, H. Miyake, T. Fujii, S. Takakura, and T. Goto The structure of human recombinant aldose reductase complexed with the potent inhibitor zenarestat Acta Cryst. D 58 2002 622 626
6. S. Miyamoto Recent advances in aldose reductase inhibitors: potential agents for the treatment of diabetic complications Exp. Opin. Ther. Patents 12 2002 621 631
7. C. Modrakowski, S.C. Flores, M. Beinhoff, and A.D. Schlüter Synthesis of pyrene containing building blocks for dendrimer synthesis Synthesis 2001 2143 2155
8. A. Podjarny, R.E. Cachau, T. Schneider, M. Van Zandt, and A. Joachimiak Subatomic and atomic crystallographic studies of aldose reductase: implications for inhibitor binding Cell. Mol. Life Sci. 61 2004 763 773
9. 2 receptors J. Med. Chem. 38 1995 2938 2945
10. D. Rakowitz, B. Hennig, M. Nagano, S. Steger, L. Costantino, and B. Matuszczak Synthesis of novel benzoic acid derivatives with benzothiazolyl subunit and evaluation as aldose reductase inhibitors Arch. Pharm. Chem. Life Sci. 338 2005 411 418
11. D. Rakowitz, P. Muigg, N. Schröder, and B. Matuszczak On the synthesis of bioisosters of O-benzothiazolyloxybenzoic acids and evaluation as aldose reductase inhibitors Arch. Pharm. Chem. Life Sci. 338 2005 419 426
12. A. Urzhumtsev, F. Tete-Favier, A. Mitschler, J. Barbanton, P. Barth, L. Urzhumtseva, J.F. Biellmann, A.D. Podjarny, and D. Moras A " specificity" pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil Structure (London) 5 1997 601 612
13. D.K. Wilson, I. Tarle, J.M. Petrash, and F.A. Quiocho Refined 1.8 Å structure of human aldose reductase complexed with the potent inhibitor zopolrestat Proc. Natl. Acad. Sci. U.S.A. 90 1993 9847 9851